Joshua D. Mezrich, MD

Portrait of Joshua D. Mezrich, MD
Assistant Professor
H4/780 CSC
600 Highland Avenue
Madison, WI 53792
(608) 263-9903
Focus Groups: 
MD, Cornell University Medical College
Research Summary: 
Transplant tolerance
Research Detail: 

Joshua D. Mezrich, MD joined the UW Transplant Team in 2007, following completion of a transplant fellowship at the University of Wisconsin. He is certified by the American Board of Surgery and his practice focuses on kidney and liver transplantation.

Selected Publications: 
Jankowska-Gan E, Sheka A, Sollinger HW, Pirsch JD, Hofmann RM, Haynes LD, Armbrust MJ, Mezrich JD, Burlingham WJ. Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs. Transplantation 2012 Feb 15; 93(3):283-90.
LaMattina JC, Mezrich JD, Hofmann RM, Foley DP, D'Alessandro AM, Sollinger HW, Pirsch JD. Alemtuzumab as compared to alternative contemporary induction regimens. Transpl. Int. 2012 May; 25(5):518-26.
Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK. Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers. Gastroenterology 2012 Jul; 143(1):88-98.e3.
Mezrich JD, Pirsch JD, Fernandez LA, Foley DP, Bellingham JM, Odorico JS, Leverson GE, Munoz-Del-Rio A, Sollinger HW, Kaufman DB, D'Alessandro AM. Differential outcomes of expanded-criteria donor renal allografts according to recipient age. Clin J Am Soc Nephrol 2012 Jul; 7(7):1163-71.
Lamattina JC, Foley DP, Fernandez LA, Pirsch JD, Musat AI, D'Alessandro AM, Mezrich JD. Complications associated with liver transplantation in the obese recipient. Clinical transplantation 2012 Jun 13.
Weiss MJ, Guenther DA, Mezrich JD, Sahara H, Ng CY, Meltzer AJ, Sayre JK, Cochrane ME, Pujara AC, Houser SL, Sachs DH, Rosengard BR, Allan JS, Benichou G, Madsen JC. The indirect alloresponse impairs the induction but not maintenance of tolerance to MHC class I-disparate allografts. Am J Transplant 2009; 9(1): 105-13.
Stevens EA, Mezrich JD, Bradfield CA. The aryl hydrocarbon receptor: A perspective on potential roles in the immune system. Immunology 2009; In Press.
Pascual J, Mezrich JD, Djamali A, Leverson G, Chin LT, Torrealba J, Bloom D, Voss B, Becker BN, Knechtle SJ, Sollinger HW, Pirsch JD, Samaniego MD. Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Transplantation. 2007 Jun 15;83(11):1429-34.